Smithsonian Magazine on MSN
A New Trial Put Immune System-Boosting Therapies to the Test to Fight HIV, Raising Hopes for Keeping the Virus at Bay
In the small study, seven out of ten participants maintained low levels of HIV for several months after receiving the ...
UCSF researchers have found a treatment for HIV that shows potential as a long-term solution for the chronic disease that, up ...
People infected with HIV must take antiretroviral drugs for life. But engineered antibodies appeared to suppress the virus ...
Seven of 10 volunteers kept HIV at bay for months after stopping meds, a rare result scientists call a major step toward a ...
HIV treatment has entered a revolutionary new era, one where a single yearly injection can keep the virus undetectable, and ...
A small UCSF study has shown promising signs of a potential functional HIV cure. After receiving a mix of vaccines, ...
A new study from UC San Francisco shows it may be possible to control HIV without long-term antiviral treatment—an advance ...
UCSF researchers have made strides toward an HIV cure, showing experimental immunotherapy can help control the virus without ...
For breastfeeding women who have HIV, consistently taking antiretroviral therapy (ART) is essential for their own health and ...
A new study conducted across three African countries has found that an injectable HIV treatment--Cabotegravir/Rilpivirine (CAB LA + RPV LA), administered every two months--is safe, well tolerated, and ...
News-Medical.Net on MSN
Long-acting HIV treatment could improve outcomes for breastfeeding women
Sujata Tewari, BA, previously of the Medical Practice Evaluation Center (MPEC) at Massachusetts General Hospital, and Andrea ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results